These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 82464)

  • 1. Alpha-fetoprotein in the diagnosis of hepatoma.
    Phillips P; Rowland R; Reid DP; Coles M
    Br Med J; 1978 Nov; 2(6149):1432. PubMed ID: 82464
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictive value of serum alpha-fetoprotein in cirrhosis.
    Colombo M
    Hepatology; 1994 Dec; 20(6):1650. PubMed ID: 7527009
    [No Abstract]   [Full Text] [Related]  

  • 3. Accuracy of α-fetoprotein measurement in detection of hepatocellular carcinoma--1 more nail in the coffin.
    Giannini EG; Trevisani F
    Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2138-9. PubMed ID: 25014652
    [No Abstract]   [Full Text] [Related]  

  • 4. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
    Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M
    Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemical and immunologic diagnosis of cancer. Hepatocellular cancer.
    Hirai H
    Tumour Biol; 1987; 8(2-3):86-93. PubMed ID: 2452470
    [No Abstract]   [Full Text] [Related]  

  • 6. The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis.
    Arrieta O; Cacho B; Morales-Espinosa D; Ruelas-Villavicencio A; Flores-Estrada D; Hernández-Pedro N
    BMC Cancer; 2007 Feb; 7():28. PubMed ID: 17288606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoproteinemia A and alpha-fetoprotein in the diagnosis of hepatocellular carcinoma and cirrhosis: several interpretations.
    Poynard T
    Hepatology; 1990 May; 11(5):892-3. PubMed ID: 1693356
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum alpha-foetoprotein: diagnostic significance in liver disease.
    Prakash C; Kumar R; Gupta RR; Lal MM; Mehrotra GC
    Indian J Pathol Microbiol; 1976 Jan; 19(1):49-55. PubMed ID: 61942
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnostic and prognostic importance of the alpha-fetoprotein test in liver cancer and cirrhosis].
    Khazanov AI; Gerasimov GM
    Klin Med (Mosk); 1986 Apr; 64(4):80-5. PubMed ID: 2425125
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical significance of alpha-fetoprotein assay as a tumor marker].
    Endo Y; Iino S; Miyazaki J
    Nihon Rinsho; 1990 Feb; 48 Suppl():949-52. PubMed ID: 1693988
    [No Abstract]   [Full Text] [Related]  

  • 11. α-Fetoprotein in hepatocellular carcinoma surveillance: mend it but do not end it.
    El-Serag HB; Kanwal F
    Clin Gastroenterol Hepatol; 2013 Apr; 11(4):441-3. PubMed ID: 23376321
    [No Abstract]   [Full Text] [Related]  

  • 12. [Alpha-fetoprotein as a tumor marker].
    Yachi A; Suga M
    Nihon Rinsho; 1980 Dec; 38(12):4554-9. PubMed ID: 6166768
    [No Abstract]   [Full Text] [Related]  

  • 13. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
    Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
    Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [alpha-1 fetoproteins in the diagnosis of hepatoma and teratogenic neoplasms].
    Lehmann FG
    Med Lab (Stuttg); 1977 Apr; 30(4):87-99. PubMed ID: 69254
    [No Abstract]   [Full Text] [Related]  

  • 15. Alpha-fetoprotein concentrations measured by radioimmunoassay in diagnosing and excluding hepatocellular carcinoma.
    Johnson PJ; Portmann B; Williams R
    Br Med J; 1978 Sep; 2(6138):661-3. PubMed ID: 81086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reference change value for alpha-fetoprotein and its application in early detection of hepatocellular carcinoma in patients with hepatic disease.
    Trapé J; Botargues JM; Porta F; Ricós C; Badal JM; Salinas R; Sala M; Roca A
    Clin Chem; 2003 Jul; 49(7):1209-11. PubMed ID: 12816928
    [No Abstract]   [Full Text] [Related]  

  • 17. [Assay of alpha-fetoprotein by monoclonal antibodies: progress in the diagnosis of hepatocellular carcinoma?].
    Bergman JF; Labadie H; Beaugrand M
    Gastroenterol Clin Biol; 1985 Oct; 9(10):742. PubMed ID: 2415422
    [No Abstract]   [Full Text] [Related]  

  • 18. [Variable clinical symptoms of hepatocellular carcinoma].
    Struve C; Heusermann U
    Dtsch Med Wochenschr; 1988 Feb; 113(8):294-6. PubMed ID: 2449323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When is a tumor marker a laboratory test?
    Galen RS
    Ann Clin Lab Sci; 1977; 7(1):51-6. PubMed ID: 65149
    [No Abstract]   [Full Text] [Related]  

  • 20. [Measurement of alpha-fetoprotein with L3 fraction in the early diagnosis of patients with hepatocellular carcinoma].
    Aoyagi Y; Suda T; Kawai H; Tamura Y; Igarashi M
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():665-9. PubMed ID: 20960847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.